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ABSTRACT 
This study tested the hypothesis that ischemic preconditioning (IPC) would increase critical 
power (CP) during a 3 minute all-out cycling test. Twelve males completed two 3 minute all-
out cycling tests, in a crossover design, separated by 7 days. These tests were preceded by 
IPC (4 x 5 minute intervals at 220 mmHg bilateral leg occlusion) or SHAM treatment (4 x 5 
minute intervals at 20 mmHg bilateral leg occlusion). CP was calculated as the mean power 
output during the final 30 s of the 3 minute test with W′ taken as the total work done above 
CP. Muscle oxygenation was measured throughout the exercise period. There was a 15.3 ± 
0.3% decrease in muscle oxygenation (TSI; [Tissue saturation index]) during the IPC 
stimulus, relative to SHAM. CP was significantly increased (241 ± 65 W vs. 234 ± 67 W), 
whereas W′ (18.4 ± 3.8 vs 17.9 ± 3.7 kJ) and total work done (TWD) were not different (61.1 
± 12.7 vs 60.8 ± 12.7 kJ), between the IPC and SHAM trials. IPC enhanced CP during a 3 
minute all-out cycling test without impacting W′ or TWD. The improved CP after IPC might 
contribute towards the effect of IPC on endurance performance.    
 
Key Words: W Prime; High intensity exercise; near-infrared spectroscopy; priming; 
occlusion. 
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INTRODUCTION 
Ischemic preconditioning (IPC) is a technique that applies a blood pressure cuff or tourniquet 
to a limb to induce repeated cycles of brief ischemia followed by reperfusion (de Groot et al. 
2010). IPC has been shown to improve exercise performance across a range of exercise tasks 
(de Groot et al. 2010, Barbosa et al. 2015, Crisafulli et al. 2011, Kjeld et al. 2014, Jean-St-
Michel et al. 2011, Patterson et al. 2015), but existing evidence suggests that IPC is more 
likely to improve performance during endurance exercise tests that rely predominantly on 
aerobic metabolism (de Groot et al. 2010, Barbosa et al. 2015, Crisafulli et al. 2011, Kjeld et 
al. 2014, Bailey et al. 2012b, Kido et al. 2015), compared to short-duration high-intensity 
exercise tests that mandate a high anaerobic energy turnover (Crisafulli et al. 2011, Gibson et 
al. 2015, Paixao, da Mota & Marocolo 2014). However, while IPC is more likely to be 
ergogenic during endurance exercise, the mechanisms that underlie the ergogenic effects of 
IPC are unclear.   
An important determinant of endurance exercise performance and the maximal sustainable 
rate of aerobic metabolism is the critical power (CP; Poole et al. 2016). Indeed CP, the 
asymptote of the hyperbolic power-duration relationship, has been reported to represent the 
highest power output that can be sustained without a progressive loss of homeostasis (Poole 
et al. 2016, Moritani et al. 1981). On the other hand, the curvature constant of the power-
duration hyperbola, W′, is a parameter predominantly underpinned by anaerobic metabolism 
(Moritani et al. 1981). Importantly, the tolerable duration of high-intensity exercise, or the 
time required to complete a set amount of work, can be accurately predicted from the 
interaction between CP and W′ (Vanhatalo, Doust & Burnley 2007). Accordingly, the 
improved endurance performance previously reported after IPC might be linked to an 
increase in CP and/or W′.     
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Studies using near-infrared spectroscopy (NIRS) have reported that skeletal muscle 
[deoxyhaemoglobin] ([HHb]) is increased after IPC (Barbosa et al. 2015, Kjeld et al. 2014, 
Kido et al. 2015, Bailey et al. 2012a), suggestive of an increase in muscle O2 extraction 
(Grassi et al. 2003). Interventions that increase muscle O2 extraction have the potential to 
speed O2 kinetics (Breese et al. 2013), which has been associated with an increase in CP 
(Vanhatalo et al. 2010, Murgatroyd et al. 2011). In addition, IPC has been suggested to 
increase production of nitric oxide (NO; Rassaf et al. 2014), a potent vasoactive metabolite.  
Therefore, IPC might also have the potential to increase skeletal muscle O2 delivery during 
exercise. The CP has been shown to be sensitive to O2 delivery as evidenced by increased CP 
when O2 delivery is elevated (Vanhatalo et al. 2010) and lower CP when O2 delivery is 
attenuated (Broxterman et al. 2015). Therefore, IPC has the potential to increase skeletal 
muscle O2 supply and utilisation.  These positive changes in skeletal muscle O2 supply and 
utilisation might positively impact on CP promoting enhanced endurance exercise 
performance. However, this has yet to be investigated.  The aim of the present study was to 
investigate the effect of IPC on CP and W′ assessed using a 3 minute all-out cycling test.  
NIRS was used to provide information on the balance between skeletal muscle O2 supply and 
utilisation, to explore the potential mechanisms for any improvements in CP and W′ 
following IPC. It was hypothesised that IPC would increase CP in association with a higher 
TSI, without altering W′.   
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METHODS 
Twelve recreationally-active males (age 30 ± 6 years; stature 1.8 ± 0.1 m; body mass 82.1 ± 
10.7 kg; sum of 7-sites 74.1 ± 19.3 mm; V̇O2peak 4.18 ± 0.86 L·min-1; Training time per 
week 7 ± 3 hr; mean ± SD) volunteered to participate in the experiment. Participants were 
informed of the nature of the research, but remained naïve to the study rationale to remove 
any placebo effect of IPC, and provided written informed consent to participate in the study. 
Participants were clear of contraindications that would preclude them from participating in 
high intensity exercise after the application of an IPC protocol. Approval for the study was 
granted by the St. Mary’s University ethics committee, which conformed to the Declaration 
of Helsinki. 
All participants reported to the laboratory on five separate occasions to perform an 
incremental ramp cycle ergometer test for the determination of V̇O2peak and gas exchange 
threshold (GET), two 3 minute all-out test familiarisation trials, and in a single blind, 
counterbalanced, crossover study design two trials consisting of IPC or SHAM interventions 
prior to a 3 minute all-out test. A minimum of 48 h rest separated each of the initial 
incremental and familiarisation tests, and a minimum of seven days separated the intervention 
trials to eliminate possible carryover of acute IPC (Loukogeorgakis et al. 2005). All testing 
was completed within 21 days in the same laboratory (temperature: 18 ± 1° C) at the same 
time of day ± 1 h. Throughout the experimental period, participants were instructed to follow 
their normal diet and fluid intake habits, with a specific request to refrain from caffeine, 
alcohol, and exercise, 24 h prior to testing.  
During the first visit, anthropometric measurements of participants were obtained and the 
cycle ergometer was individually set up, with measurements recorded and replicated for all 
subsequent trials. Participants then performed an incremental ramp cycling protocol on an 
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electronically-braked cycle ergometer (Lode Excalibur Sport, Lode BV, Groningen, 
Netherlands) to assess V̇O2peak and GET. The protocol consisted of a three minute unloaded 
baseline pedalling warm up phase, followed immediately by a 30 W·min-1 ramp protocol. 
Participants self-selected a cadence between 75 - 95 rpm during the unloaded period, where 
they cycled freely for the initial 60 s, confirming their comfort at that cadence. The test ended 
at volitional exhaustion or was terminated when the self-selected pedal cadence reduced by 5 
rpm for more than 10 seconds. Pulmonary gas exchange was measured breath-by-breath 
throughout the test. V̇O2peak was taken as the highest 30 s average recorded during the test, 
with V̇O2 and V̇CO2 data reduced to 5 s intervals for the estimation of the GET using the V-
slope method (Beaver, Wasserman & Whipp 1986; Bailey et al. 2009). Briefly, two 
researchers performed independent analysis of GET using the following cluster of 
measurements; a) the first disproportionate increase in CO2 production from visual inspection 
of individual plots of CO2 vs. O2; b) an increase in expired ventilation ( E)/ O2 with no 
increase in E/ CO2; and 3) an increase in end-tidal O2 tension with no fall in end-tidal CO2 
tension. To account for the time delay in the increase in O2 to the increase in the external 
work-rate during incremental exercise, the work-rate corresponding to GET was reduced by 
two thirds of the ramp rate (i.e. 20 W; Whipp, 1987). 
During the next two visits, participants performed the 3 minute all-out exercise test as 
described below. For the main experimental trials, participants arrived at the laboratory for 
initial assessment of body mass.  Thereafter, participants were required to lie in a semi-supine 
position on an adjustable medical couch where resting blood pressure was measured using an 
automated sphygmomanometer (Nissei DS-500, Japan Precision Instruments Inc., Gunma, 
Japan). During this period a wireless portable NIRS device (PortaMon MK II, Artinis 
Medical Systems, The Netherlands) was placed and prepared as described below. This 
allowed for the measurement of muscle oxygenation variables (HHb and TSI). Pneumatic 
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pressure cuffs (14.5 cm width - Delfi Medical Innovations, Vancouver, Canada) were then 
applied bilaterally and simultaneously to the proximal portion of the upper leg and inflated 
for 5 minutes followed by 5 minutes of reperfusion. This was repeated four times, lasting a 
total of 40 minutes. In the IPC condition the cuffs were inflated to 220 mmHg (Kooijman et 
al. 2008) to ensure circulatory occlusion of the limb whilst for the SHAM condition the cuffs 
were inflated to 20 mmHg (Bailey et al. 2012b). 
The test protocol began immediately after the IPC/SHAM treatment, with a 3 minute resting 
period with the participant sitting quietly on the ergometer and their right leg hanging in a 
relaxed manner. Following this, they immediately began a 5 minute warm up at 90% GET 
(performed at the participant’s previously self-selected cadence), followed by 5 minutes of 
seated passive recovery. Participants then completed a pre-test, 3 minute of unloaded cycling 
at their previously self-selected cadence with the final 10 s of this period used to increase 
cadence to ~110 rpm providing a ‘rolling start’ for the following all-out effort. A count down 
was provided to coincide with the start of the 3 minute all-out cycling test. At the beginning 
of this test participants were asked to provide a maximal effort and then sustain as high a 
cadence as possible. Strong verbal encouragement was provided throughout however, elapsed 
time feedback, displays of power output and cadence were hidden to prevent the participants 
from employing pacing strategies. Following the end of the test participants were advised to 
remain seated on the bike and cycle at a self-selected power output for 10 minutes.  
CP was calculated as the average power output in the final 30 s of the 3 minute test. W′ was 
calculated as the power-time integral above CP across the 3 minutes of work. TWD was 
calculated as the sum of 3 minutes of work done (Burnley, Doust & Vanhatalo 2006), whilst 
the peak power output achieved during the test was defined as the highest power output over 
a 5 s period during the test. To assess the potential impact of IPC on performance, estimates 
of CP and W′ were used to predict the time taken to complete a range of work targets (50, 75, 
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100, 125, 150, 175, 200, 225, 250 KJ), as previously described and using the following 
equation (Kelly et al. 2013):  
Tlim = (W-W′)/CP. 
Pulmonary gas exchange was measured throughout the entire protocol using a breath-by-
breath open spirometric system (Oxycon Pro, Jaeger Ltd., Hoechberg, Germany). The turbine 
volume transducer was calibrated using a 3 L precision syringe (Hans Rudolph Inc., 
Shawnee, USA), and the gas analyser calibrated prior to each trial using O2 and CO2 of 
known concentration (Cryoserve, Worcester, UK). Prior to analysis the breath-by-breath O2 
data from each test were treated as described previously (Bailey et al. 2011).  A single-
exponential model without time delay, with the fitting window commencing at t = 0 s 
(equivalent to the mean response time, MRT) was used to characterize the kinetics of the 
overall O2 response during the trials, using an iterative process, as described in the 
following equation:  
O2 (t) = O2 baseline + A (1-e- (t/MRT))   (Eqn. 1)                                          
where O2 (t) represents the absolute O2 at a given time t; O2baseline represents the mean 
O2 measured over the final 60-s of baseline; and A and MRT represent the amplitude and 
MRT, respectively, describing the overall increase in O2 above baseline. The absolute O2 
at end-exercise (average over the final 30-s) and the total O2 consumed were also calculated. 
Blood [lactate] was analysed at rest and 60 s post-exercise via earlobe capillary blood 
samples, collected using a heparinized 20 µl end-to-end capillary tube and assessed in an 
automatic analyser (Biosen C-Line lactate analyser, EKF Diagnostics, Penarth, UK; CV = 
1.5%). It should be noted that the blood [lactate] value 60 s post-exercise would not 
necessarily reflect the peak value from the test. Heart rate (HR) was measured continuously 
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via telemetry (RS610, Polar Electro Japan) with a whole period average value calculated for 
the cycling exercise periods.  
A wireless portable NIRS unit was located on the vastus lateralis muscle belly of the right 
leg. The location was identified with the participant in a semi-recumbent sitting pose, an 11 
cm dowel was placed under their right knee, and a mark placed 2/3 of the distal distance 
between the anterior superior iliac spine and tibiale laterale (Patterson et al. 2015). The unit 
was set to record at 10 Hz, with data converted to 1 s intervals and averaged over the final 30 
s of rest for baselinepreintervention assessment prior to the interventions and averaged over the 
accumulated 20 minutes of IPC/SHAM occlusion and reperfusion periods. The [HHb] 
kinetics during the exercise bouts was determined by fitting a mono-exponential model with a 
time delay (TD) from the nadir of the initial decline in the [HHb] response to the point at 
which mono-exponentially became distorted, consequent to a gradual fall in [HHb], as 
determined by visual inspection of the residual plots.  The TSI values at baselinepostintervention 
were averaged over 60-s preceding the onset of the trial, as well as the first 60-s and 120-s 
and last 30-s of the 180-s trial. 
Data were analysed using the Statistical Package for the Social Sciences (SPSS v21). All data 
are presented as mean ± SD. Shapiro–Wilk and Kolmogorov–Smirnov tests indicated a 
normal distribution of data. The differences between IPC and sham for CP, W′ and 
physiological measures were assessed via a two tailed paired Student’s t-test. The predicted 
performance times in IPC and SHAM conditions were analysed using a two-way repeated 
measures ANOVA (2 conditions x 8 workloads) with significant main effects further 
analysed using Tukeys honest significant difference (HSD). The level of significance was set 
at p < 0.05 for all analyses.  
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RESULTS 
V̇O2peak and power output at V̇O2peak were 4.06 ± 0.79 L·min-1 and 344 ± 52 W respectively, 
with GET occurring at 2.33 ± 0.38 L·min-1 (equivalent to 59 ± 10% of V̇O2peak) and 162 ± 38 
W. V̇O2peak during the 3 minute all-out test was 97% and 95% of the V̇O2peak value recorded 
in the ramp test for the IPC and SHAM trials. Furthermore HRmax during the 3 minute all-out 
test represented 98% and 97% of the values achieved in the ramp test for IPC and SHAM, 
respectively.  
CP was 7 ± 2 W greater following IPC compared to SHAM (Table 1, Figure 1). The 
coefficient of variation (CV) of the CP in 3 minute all-out test was 2.4% (5.5 W). There were 
no differences in W′ or TWD between IPC and SHAM (Table 1). Nor were there any 
differences in V̇O2peak, total O2 consumed, V̇O2 MRT, peak power output, post-exercise blood 
[lactate], HRmax or HRmean between IPC and SHAM (Table 1).   
When CP and W′ were combined to predict performance across a number of work done 
targets, there were significant main effects for condition and work done and a significant 
interaction (P<0.05). Post-hoc analysis revealed a significant improvement in performance 
(2.9% - 3.3%) for workloads 100-250kJ but not below 75 kJ (Figure 2).  
There were no differences in baseline TSI between IPC and SHAM (Table 2). The IPC 
intervention resulted in significantly lower TSI values during the 20 minute occlusion period 
compared to SHAM (Table 2). There were no differences in muscle TSI during the 3 minute 
all-out test between IPC and SHAM, and no significant difference for HHb TD + τ  during 
exercise  (4.3 ± 3.0 vs  6.6 ± 4.1, p = 0.081).  
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DISCUSSION 
The main findings of this study were that a bilateral IPC stimulus of the lower limbs 
increased CP by 7 W (~3%), but had no effect on W′ or TWD, during a 3 minute all-out test 
compared to a SHAM condition. These observations are consistent with our hypotheses. The 
increased CP was predicted to improve endurance exercise performance, particularly during 
longer duration trials, as demonstrated in figure 2. These findings suggest that IPC can 
improve CP without impacting W′, and is more likely to enhance performance in events 
where the mean power output is in the lower compared to the upper limits of the severe-
intensity exercise domain.   
The predicted 2-3% improvement in endurance performance in this study supports a number 
of studies demonstrating enhanced performance after IPC, including a 2.5% improvement in 
5 km time trial performance (Bailey et al. 2012b) and 1% improvement in 1 km rowing 
ergometer time trial performance (Kjeld et al. 2014). In the current study, CP was increased 
concomitant with no increase in V̇O2peak or W′ between the IPC and SHAM trials. Although 
the improvement in CP was small (3%), the potential practical significance of this change can 
be recognised if one considers that the inter-relationship between CP and W′ can be used to 
accurately predict performance times within the severe intensity domain (Kelly et al. 2013). 
Indeed, the 3% increase in CP with IPC in this study was predicted to translate into a 2-3% 
improvement in the time to complete a fixed amount of work, except for the two lowest work 
targets.  Therefore, these findings suggest that IPC has the potential to improve time trial 
performance in the severe intensity domain, consequent to enhanced CP. Consistent with this 
postulate, CP derived from the 3 minute all-out test has been shown to predict 16.1km road 
time trial performance (Black et al. 2014), however it is unlikely that it could be used to 
directly predict performance time as this was > 25 min so likely not in the severe-intensity 
domain for some athletes. Increasing CP therefore would allow an individual to cycle, in the 
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severe intensity domain, at a higher power output before a precipitous increase in fatigue 
related metabolites and decline in finite anaerobic energy reserves occurs (Vanhatalo et al. 
2016, Poole et al. 1988, Jones et al. 2008), which might underlie any improvements in 
exercise performance after IPC.  
In line with our experimental hypothesis, the IPC protocol, which provided 20 minutes of 
occlusion, resulted in a 15.3% reduction in TSI (a marker of the dynamic balance between 
muscle O2 supply and consumption) compared with the SHAM intervention. IPC has been 
shown to increase circulating concentrations of nitrite, a key physiological signalling 
molecule and marker of endothelial nitric oxide synthase (eNOS) activity, through the sheer 
stress imposed on the vascular endothelium during the reperfusion period and the resultant 
activation of eNOS  (Rassaf et al. 2014). Nitrite, and its potential to undergo O2-independent 
reduction to NO, has several biological functions including the regulation of vascular tone, 
blood flow and mitochondrial respiration (Stamler, Meissner 2001). Therefore, IPC has the 
potential to influence muscle oxygenation responses, as evidenced by greater muscle 
oxygenation in rats during exercise (Saito et al. 2004) and faster HHb kinetics during 
moderate-intensity cycling exercise (Kido et al. 2015). Moreover, greater deoxygenated 
haemoglobin and myoglobin concentrations have been observed following IPC in human 
skeletal muscle during handgrip exercise, suggesting increased O2 extraction (Barbosa et al. 
2015). However, there were no differences in TSI or HHb kinetics between conditions during 
the 3 minute all-out test in the present study.    
IPC had no effect on W′, and since W′ is closely associated with the depletion of finite 
anaerobic energy reserves and the accumulation of metabolites derived from anaerobic 
energy pathways (Miura, Sato, Whipp, & Fukuba, 2000), our finding suggests  that IPC did 
not measurably impact anaerobic energy processes during the 3 min all out test. This 
observation supports previous research which has demonstrated no improvement in 
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performance following IPC when anaerobic metabolism was the predominant energy system 
utilised (Gibson et al. 2015; Paixão et al., 2014). In contrast, Patterson and colleagues (2015) 
demonstrated peak and mean power output were increased in the early stages of a land based 
repeated sprint protocol, which demonstrated improved performance in the early stages 
following IPC. It should be noted that there are some important differences between this 
current study and previous work, particularly with regard to the timing of the IPC 
intervention. In the current study the exercise commenced within 8 minutes of the last 
occlusion cycle which is a similar time frame to previous work showing no effect of IPC on 
anaerobic performance (Gibson et al 2015; Paixão et al., 2014). In contrast, work from 
Patterson et al. (2015) demonstrated improved anaerobic performance 45 minutes post IPC 
application and a recent meta-analysis suggests this time frame has a larger effect on 
anaerobic performance (Salvador et al. 2016).  Taken together, these findings suggest that the 
timing of the IPC intervention may have implications for the metabolic pathways and 
component of the hyperbolic power-duration relationship that are potentiated following IPC 
administration. 
IPC enhances CP which may translate to improved exercise performance particularly in the 
severe intensity domain. The % change for CP was greater than the CV (2.4%), indicating 
that the effect was greater than the typical measurement error.  Alongside the improvement in 
CP, the changes in predicted performance across a range of time trials (2.9 - 3.3%) may be 
practically meaningful as they are larger than the 0.6% value suggested to be the smallest 
‘worthwhile’ improvement for road time trial cyclists (Paton, Hopkins 2001).  Therefore, our 
data support the use of IPC as a pre competition intervention to enhance endurance exercise 
performance.  
There are several limitations with this study. When fitting pulmonary V̇O2 kinetics, 
researchers normally average several bouts of exercise in order to reduce the signal to noise 
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ratio. In the current study we only employed a single bout of exercise. In this case, we used a 
mean response time to give an appreciation of the overall response dynamics, rather than 
attempting to precisely characterise the phase II time constant.  Since the amplitude is large 
the confidence in the fitting procedure is enhanced as there are more data points to fit the 
exponential through. Furthermore we also used one exercise bout to fit muscle NIRS kinetics. 
Kido et al. (2015) suggest that one trial may be sufficient to model muscle kinetics. Due to 
the high frequency of sampling (10Hz) we believe that modelling NIRS kinetics are reliable 
even with one trial. Furthermore, one transition is appropriate as the data is less noisy, 
compared to breath-by-breath V̇O2 data so the signal to noise ratio is improved. A further 
limitation of NIRS is that increased skin perfusion might influence light absorbance and 
scattering and, thus, the NIRS-derived variables.  However, Tew et al. (2010) demonstrated 
that while thigh heating increased cutaneous vascular conductance and vastus lateralis total 
haemoglobin concentration, muscle oxygenation was increased with heating at rest but not 
during exercise.  On the other hand, Messere and Roatta (2013) observed no change in 
muscle oxygenation with local heating at rest or during exercise.  Therefore, the effects of 
skin blood flow on TSI are controversial at rest, but less so during exercise. Future research 
should focus on investigating the pulmonary and muscle kinetics with multiple exercise bouts 
following IPC. Furthermore emphasis should be placed on optimising the most appropriate 
time that IPC can be applied before competition / performance. Alongside this more focus 
should be placed on the plasma and muscle mediators that may underlie the physiological and 
performance effects of IPC.   
CONCLUSIONS 
In conclusion, our findings suggest that IPC can improve CP, but not W′, during a 3 minute 
all-out test in healthy men. The increase in CP in the IPC trial was predicted to evoke 
practically meaningful improvements in cycling time trial performance when the work to be 
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completed is in the range of 100-250 kJ (Figure 2). Therefore, our study supports the use of 
IPC as a novel, cost-effective intervention to improve CP with potential to enhance endurance 
exercise performance in humans.   
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FIGURE LEGENDS 
 
Figure 1. CP measured during the 3 min all-out test following IPC and SHAM interventions. 
Values are means ± SD. * Significant difference between IPC and SHAM (P<0.05). 
 
Figure 2. Predicted time to complete targets of work done (50 – 250 kJ).  Values are means ± 
SD. * Significant difference between IPC and SHAM (P<0.05). 
 
 
TABLE LEGENDS 
 
Table 1. Physiological variable responses to IPC and SHAM during the 3 min all-out test. 
 
Table 2. Effect of the IPC and SHAM interventions on TSI responses before and during the 3 
min all-out test.  
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Table 1 
 
  IPC SHAM  p value  
       
 CP (W) 241 ± 65 234 ± 67  0.011  
 W′ (kJ)  17.9 ± 3.7 18.4 ± 3.8  0.355  
 TWD (kJ)  60.8 ± 12.7 61.1 ± 12.7  0.830  
 PPO (W) 821 ± 186 823 ± 204  0.869  
 V̇O2peak (L·min-1) 
 
Total O2 consumed (L) 
 
V̇O2 MRT (s) 
 
3.93 ± 0.67 
 
10.86 ± 1.75 
 
15 ± 6 
3.85 ± 0.74 
 
10.98 ± 2.15 
 
15 ± 6 
 0.298 
 
0.719 
 
0.863 
 
 Blood [lactate] (mmol.L-1) 12.7 ± 2.1 11.9 ± 1.3  0.212  
 HRmean (bpm) 
 
HRmax (bpm) 
163 ± 18 
 
177 ± 9 
160 ± 20 
 
176 ± 9 
 0.257 
 
0.331 
 
CP, critical power; TWD, total work done; PPO, peak power output; MRT, mean response 
time; HR, heart rate. Data are mean ± SD. 
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Table 2 
 
  IPC SHAM p value  
 Baseline (%) 72.4 ± 3.9 71.8 ± 3.0 0.480  
 Intervention (%)  56.4 ± 0.7 71.7 ± 0.9 0.001  
 Exercise - 60-s (%) 
 
Exercise - 120-s (%) 
 
End-Exercise (%) 
 
46.3 ± 8.6 
 
47.4 ± 9.8 
 
47.5 ± 10.0 
 
45.1 ± 10.5 
  
46.0 ± 10.9 
 
45.8 ± 11.0 
0.582 
 
0.495 
 
0.371 
 
TSI, tissue saturation index. Data are mean ± SD. 
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Figure 2 
